ArcelorMittal - New York Shares - Level III ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für ArcelorMittal - New York Shares - Level III zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um ArcelorMittal - New York Shares - Level III zu Deinem Portfolio hinzuzufügen.
ArcelorMittal - New York Shares - Level III Aktie News
Luxembourg, May 2 , 20 24 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company, today announced results1 for the three-month period ended March 31, 2024.
30 April 2024, 18:15 CET The Annual General Meeting (‘General Meeting') of shareholders of ArcelorMittal held today in Luxembourg approved all resolutions by a strong majority. 78.47% of the voting rights were represented at the General Meeting.
25 April 2024, 14:30 CET ArcelorMittal (‘the Company') today announces the publication of its first quarter 2024 sell-side analyst consensus figures. The consensus figures are based on analysts' estimates recorded on an external web-based tool provided and managed by an independent company, Visible Alpha.
23 April 2024, 15:00 CET Today, ArcelorMittal (‘the company') published its 2023 Integrated Annual Review (‘IAR'), which can be accessed here annualreview2023.arcelormittal.com . The 2023 IAR, ‘Preparing for the future', is structured in nine main chapters: Our business and material issues Driving change in our safety performance Responsible energy use and lower-carbon futures Air, water, land,...
Things seemed to be slowing down after interest rates were raised eleven times in the previous 18 months, but according to the most recent data, the inflation rate for the last 12 months as of March is 3.5%, which has many people searching for steel stocks to sell from their portfolio. The logic is straightforward.
NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the presentation of the latest research from the pridopidine Huntington disease (HD) and amyotrophic lateral s...
10 April 2024, 16:45 CET ArcelorMittal (‘the Company') announced in December 2023 that it had engaged dss+, a leading provider of sustainable operations management consulting services, to conduct a company-wide audit of its safety practices. Today, it shares a first interim update about what has been achieved in the first three months of the audit, and the scale and scope of the work underway.
New content series features insights from ArcelorMittal's global leadership team through ‘ Steel Thoughts ' opinion column and ‘ Steel Talks ' podcast
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.